Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Thursday, May 9, 2024.
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)
Long-Term Uptrend (+90) - CRNX is in a strong uptrend that is likely to continue. While CRNX is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid CRNX?
MarketClub looks at technical strength and momentum to determine if the timing is right for CRNX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CRNX
The long-term trend has been UP since Sep 11th, 2023 at 22.49
The intermediate-term trend has been UP since May 8th, 2024 at 48.37
The short-term trend has been UP since May 1st, 2024 at 45.22
Smart Scan Analysis for CRNX
Based on our trend formula, CRNX is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 51.000 | 51.000 | 49.750 | 50.135 | -0.755 |
| Prev. Close | Volume | Bid | Ask | Time |
| 50.890 | 216868 | 2024-05-09 11:35:15 |
| Year High | 42 | Year High Date | 2018-09-10 |
| Year Low | 19.23 | Year Low Date | 2018-07-18 |
| 52wk High | 51.29 | 52wk High Date | 2024-05-08 |
| 52wk Low | 15.76 | 52wk Low Date | 2023-09-08 |
| Average Volume | 710,426 | Shares Outstanding | 69,596 |
| Market Cap | 425M | Assets | 635,353,000M |
| Liabilities | 96,247,000M | P/E Ratio | -7.20140000 |
| Volatility | 75.6 |